Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 156

Similar articles for PubMed (Select 17088249)

1.

LIND/ABIN-3 is a novel lipopolysaccharide-inducible inhibitor of NF-kappaB activation.

Wullaert A, Verstrepen L, Van Huffel S, Adib-Conquy M, Cornelis S, Kreike M, Haegman M, El Bakkouri K, Sanders M, Verhelst K, Carpentier I, Cavaillon JM, Heyninck K, Beyaert R.

J Biol Chem. 2007 Jan 5;282(1):81-90. Epub 2006 Nov 6.

2.

ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling.

Verstrepen L, Carpentier I, Verhelst K, Beyaert R.

Biochem Pharmacol. 2009 Jul 15;78(2):105-14. doi: 10.1016/j.bcp.2009.02.009. Epub 2009 Feb 27. Review.

PMID:
19464428
3.

Identification of a novel A20-binding inhibitor of nuclear factor-kappa B activation termed ABIN-2.

Van Huffel S, Delaei F, Heyninck K, De Valck D, Beyaert R.

J Biol Chem. 2001 Aug 10;276(32):30216-23. Epub 2001 Jun 4.

4.

Expression of the NF-kappaB inhibitor ABIN-3 in response to TNF and toll-like receptor 4 stimulation is itself regulated by NF-kappaB.

Verstrepen L, Adib-Conquy M, Kreike M, Carpentier I, Adrie C, Cavaillon JM, Beyaert R.

J Cell Mol Med. 2008 Jan-Feb;12(1):316-29. Epub 2007 Dec 10.

5.

FLN29, a novel interferon- and LPS-inducible gene acting as a negative regulator of toll-like receptor signaling.

Mashima R, Saeki K, Aki D, Minoda Y, Takaki H, Sanada T, Kobayashi T, Aburatani H, Yamanashi Y, Yoshimura A.

J Biol Chem. 2005 Dec 16;280(50):41289-97. Epub 2005 Oct 12.

6.

Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes.

Zhang FX, Kirschning CJ, Mancinelli R, Xu XP, Jin Y, Faure E, Mantovani A, Rothe M, Muzio M, Arditi M.

J Biol Chem. 1999 Mar 19;274(12):7611-4.

7.

The biology of A20-binding inhibitors of NF-kappaB activation (ABINs).

Verstrepen L, Carpentier I, Beyaert R.

Adv Exp Med Biol. 2014;809:13-31. Review.

PMID:
25302363
8.

ABIN-3: a molecular basis for species divergence in interleukin-10-induced anti-inflammatory actions.

Weaver BK, Bohn E, Judd BA, Gil MP, Schreiber RD.

Mol Cell Biol. 2007 Jul;27(13):4603-16. Epub 2007 May 7.

9.

ABINs inhibit EGF receptor-mediated NF-kappaB activation and growth of EGF receptor-overexpressing tumour cells.

Huang L, Verstrepen L, Heyninck K, Wullaert A, Revets H, De Baetselier P, Beyaert R.

Oncogene. 2008 Oct 16;27(47):6131-40. doi: 10.1038/onc.2008.208. Epub 2008 Jul 14.

PMID:
18622428
10.
11.

Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1.

Heyninck K, Kreike MM, Beyaert R.

FEBS Lett. 2003 Feb 11;536(1-3):135-40.

PMID:
12586352
12.

ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB.

Mauro C, Pacifico F, Lavorgna A, Mellone S, Iannetti A, Acquaviva R, Formisano S, Vito P, Leonardi A.

J Biol Chem. 2006 Jul 7;281(27):18482-8. Epub 2006 May 9.

13.

TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain.

Kawamoto T, Ii M, Kitazaki T, Iizawa Y, Kimura H.

Eur J Pharmacol. 2008 Apr 14;584(1):40-8. doi: 10.1016/j.ejphar.2008.01.026. Epub 2008 Feb 5.

PMID:
18299127
14.

Overexpression of ABIN-2, a negative regulator of NF-kappaB, delays liver regeneration in the ABIN-2 transgenic mice.

Li CC, Chou CK, Wang MH, Tsai TF.

Biochem Biophys Res Commun. 2006 Mar 31;342(1):300-9. Epub 2006 Feb 2.

PMID:
16480954
15.

TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta.

Oshiumi H, Sasai M, Shida K, Fujita T, Matsumoto M, Seya T.

J Biol Chem. 2003 Dec 12;278(50):49751-62. Epub 2003 Sep 30.

17.

A20 inhibits toll-like receptor 2- and 4-mediated interleukin-8 synthesis in airway epithelial cells.

Gon Y, Asai Y, Hashimoto S, Mizumura K, Jibiki I, Machino T, Ra C, Horie T.

Am J Respir Cell Mol Biol. 2004 Sep;31(3):330-6. Epub 2004 May 13.

PMID:
15142865
18.

Human lactoferrin activates NF-kappaB through the Toll-like receptor 4 pathway while it interferes with the lipopolysaccharide-stimulated TLR4 signaling.

Ando K, Hasegawa K, Shindo K, Furusawa T, Fujino T, Kikugawa K, Nakano H, Takeuchi O, Akira S, Akiyama T, Gohda J, Inoue J, Hayakawa M.

FEBS J. 2010 May;277(9):2051-66. doi: 10.1111/j.1742-4658.2010.07620.x. Epub 2010 Mar 19.

PMID:
20345905
19.

Acrolein with an alpha, beta-unsaturated carbonyl group inhibits LPS-induced homodimerization of toll-like receptor 4.

Lee JS, Lee JY, Lee MY, Hwang DH, Youn HS.

Mol Cells. 2008 Apr 30;25(2):253-7. Epub 2008 Mar 31.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk